Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer

NCT06984250 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT06984250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06984250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid Techniques Combining Hypofractionated Whole Breast Radiotherapy With Concomitant Tumor Bed Boost in Patients With Breast Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 6, 2025
Completion date
February 28, 2030
Enrollment
315 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ductal breast carcinoma in situ, early breast cancer